Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Katharina Helene Susek"'
Publikováno v:
Frontiers in Immunology, Vol 9 (2018)
Chemokines govern leukocyte migration by attracting cells that express their cognate ligands. Many cancer types show altered chemokine secretion profiles, favoring the recruitment of pro-tumorigenic immune cells and preventing the accumulation of ant
Externí odkaz:
https://doaj.org/article/aa4e03f0258d4862a02516b6ca6a222e
Autor:
Katharina Helene Susek, Viktoria Nina Flore, Maria Karvouni, Stephan Meinke, Joe Conner, Colin Powers, Robert Allen, Arnika Kathleen Wagner, Evren Alici
Publikováno v:
Blood. 140:12440-12441
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f018728fb4b70bbd38b1e7dedcae4f88
https://doi.org/10.1182/blood-2022-158062
https://doi.org/10.1182/blood-2022-158062
Autor:
Katharina Helene Susek, Johanna Dehlsen Wersäll, Gösta Gahrton, Evren Alici, Johan Lund, Arnika Kathleen Wagner, Gabriel Afram, Hareth Nahi, Vincent Luong, Katarina Uttervall
Publikováno v:
European journal of haematologyREFERENCES. 106(4)
Introduction Novel drugs and drug combinations have improved outcomes for multiple myeloma patients. However, subgroups of patients still have a poor progression-free survival (PFS) and overall survival (OS). In an attempt to identify how the novel d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d9954a9944054d23736046cec8f1e8a0
https://pubmed.ncbi.nlm.nih.gov/33471414
https://pubmed.ncbi.nlm.nih.gov/33471414
Publikováno v:
European Journal of Haematology
COVID‐19 has emerged as a global pandemic. Cancer patients have been reported to be at higher risk for adverse outcome of COVID‐19. Studies are ongoing to decipher the risk factors and risk groups among cancer patients as well as strategies to re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ef635e5e4116d0dfa318d8709fd7bfa
Autor:
Arnika Kathleen Wagner, Hans-Gustaf Ljunggren, Evren Alici, Katharina Helene Susek, Stephan Meinke
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 19:e169
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2d5b473cc0320f2eccf0043418365031
https://doi.org/10.1016/j.clml.2019.09.282
https://doi.org/10.1016/j.clml.2019.09.282
Autor:
Afram, Gabriel1,2 (AUTHOR) Gabriel.afram@ki.se, Susek, Katharina Helene1 (AUTHOR), Uttervall, Katarina1,2 (AUTHOR), Wersäll, Johanna Dehlsen1 (AUTHOR), Wagner, Arnika Kathleen1,2 (AUTHOR), Luong, Vincent1,2 (AUTHOR), Lund, Johan1 (AUTHOR), Gahrton, Gösta1 (AUTHOR), Alici, Evren1,2 (AUTHOR), Nahi, Hareth1,2 (AUTHOR)
Publikováno v:
European Journal of Haematology. Apr2021, Vol. 106 Issue 4, p546-554. 9p.
Autor:
Susek, Katharina Helene1 (AUTHOR) katharina.susek@ki.se, Gran, Charlotte1,2 (AUTHOR), Ljunggren, Hans‐Gustaf3 (AUTHOR), Alici, Evren1,4 (AUTHOR), Nahi, Hareth1,4 (AUTHOR)
Publikováno v:
European Journal of Haematology. Dec2020, Vol. 105 Issue 6, p751-754. 4p.
Autor:
Scobioala, Sergiu, Kittel, Christopher, Niermann, Philipp, Wolters, Heidi, Susek, Katharina Helene, Haverkamp, Uwe, Eich, Hans Theodor
Publikováno v:
Strahlentherapie und Onkologie; Nov2018, Vol. 194 Issue 11, p975-984, 10p
Publikováno v:
Frontiers in Immunology; 9/25/2018, pN.PAG-N.PAG, 9p